FOXA
66
2
BAC
80
3
TEL
69
3
EXR
26
2
NKE
31
-5
FLS
63
2
CMS
60
2
BMY
78
2
PAYX
41
5
DOV
63
-6
PSX
25
-12
KSS
58
-4
AMP
70
4
TRIP
52
3
KMI
63
10
WMT
55
-4
MS
76
2
OXY
42
2
XEL
41
4
SRE
47
2
FOXA
66
2
BAC
80
3
TEL
69
3
EXR
26
2
NKE
31
-5
FLS
63
2
CMS
60
2
BMY
78
2
PAYX
41
5
DOV
63
-6
PSX
25
-12
KSS
58
-4
AMP
70
4
TRIP
52
3
KMI
63
10
WMT
55
-4
MS
76
2
OXY
42
2
XEL
41
4
SRE
47
2
Financhill
Back

ProShares Short 20+ Yr Treasury Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
80

TBF
ProShares Short 20+ Yr Treasury

Last Price:
$24.20
Seasonality Move:
1.05%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.68
Seasonality Move:
25.93%
Buy
80
ProShares Short 20+ Yr Treasury (TBF) is a Buy

Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?

  • The current ProShares Short 20+ Yr Treasury [TBF] share price is $24.26. The Score for TBF is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TBF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBF Stock Price Chart

What is ProShares Short 20+ Yr Treasury's stock price today?

  • The ProShares Short 20+ Yr Treasury share price today is $24.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBF is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

TBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.38 Buy
Relative Strength Index (14 RSI): 62.15 Buy
Chaikin Money Flow: 29021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.71 - 24.19) Buy
Bollinger Bands (100): (23.46 - 24.36) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

TBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.2 Buy
20-day SMA: 23.98 Buy
50-day SMA: 23.68 Buy
200-day SMA: 24.2 Buy
8-day EMA: 15.34 Buy
20-day EMA: 7.98 Buy
50-day EMA: 3.58 Buy
200-day EMA: 0.95 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

ProShares Short 20+ Yr Treasury Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):